CHOP VERSUS GEM‐P IN THE FIRST‐LINE TREATMENT OF T‐CELL LYMPHOMA (PTCL): INITIAL RESULTS OF THE UK NRCI PHASE II RANDOMISED CHEMO‐T TRIAL. (June 2017) - Gleeson, M.; Peckitt, C.; To, Y.M.; Edwards, L.; Chau, I.; Johnson, P.; Ardeshna, K.M.; Wotherspoon, A.; Attygalle, A.; Begum, R.; Chua, S.; Zerizer, I.; et al.